Outlook Therapeutics said the Food and Drug Administration rejected its application for a treatment of macular degeneration. The stock slid 69% to 49 cents after the bell. Rubico agreed to buy a ...

Nuvve shares fell after it closed a private placement of shares and warrants for gross proceeds of $5.4 million, before deducting expenses. The stock slipped 22% to $1.98 in after-hours trading ...

Outlook Therapeutics shares slid after the company's macular degeneration drug was once again rejected by the Food and Drug Administration. The stock dropped 71% to 45 cents a share in after-hours ...

Outlook Therapeutics received notice that the Food and Drug Administration can't approve its biologics license application for a drug designed to treat macular degeneration.

Owens & Minor completed the sale of its products and healthcare services segment and is changing its name to Accendra Health. The sale will allow the Richmond, Va., company to become a pure-play ...

Verizon's stock was rising 0.5% in recent trading, but is set to end the year as the highest yielding Dow industrials component. There's [a trading strategy referred to as the "Dogs of the Dow,"]( ...

The yield on the 10-year Treasury note fell in 2025, posting its biggest annual drop since 2020, according to Dow Jones ...

U.S. stocks were trading near the session's low in the final trading hour of 2025. The Dow Jones Industrial Average was about 222 points lower, or 0.5%, trading near 48,144 and close to the session's ...

Gold and silver both logged their best years since 1979, with the surge in metals prices driven by a desire among investors ...

Communication-services stocks were on pace to be the stock index's top-performing sector in back-to-back years, according to ...

Elanco Animal Health received approval from the Agriculture Department for Befrena, the company's antibody treatment for canine allergic and atopic dermatitis. The animal-medicine company said ...

Some corners of Wall Street were hoping 2025 would be the year that investors finally ditched money-market funds for other ...